Mitsubishi Chemical Advanced Materials company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

mcam.com

Founded Year

1933

Stage

Acquired | Acquired

Total Raised

$150M

About Mitsubishi Chemical Advanced Materials

Mitsubishi Chemical Advanced Materials is a global provider of high-performance engineering plastics that are used for machined parts in food processing and packaging, semiconductor manufacturing, aerospace, electronics, chemical processing, life sciences, power generation, and diverse industrial equipment.

Mitsubishi Chemical Advanced Materials Headquarter Location

Talstrasse 70

Zurich, 8001,

Switzerland

610-320-6600

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Mitsubishi Chemical Advanced Materials Patents

Mitsubishi Chemical Advanced Materials has filed 7 patents.

The 3 most popular patent topics include:

  • Concrete
  • Thermoplastics
  • Appropriate technology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/20/2015

7/9/2019

Thermoplastics, Operating roller coasters, Lubricants, Fullerenes, Polymers

Grant

Application Date

2/20/2015

Grant Date

7/9/2019

Title

Related Topics

Thermoplastics, Operating roller coasters, Lubricants, Fullerenes, Polymers

Status

Grant

Latest Mitsubishi Chemical Advanced Materials News

Mitsubishi Chemical Advanced Materials, AMAC cooperate on thermoplastics business in Europe

Apr 13, 2022

Partnership to strengthen and develop sustainable composite business activity internationally, includes opening of KyronTEX textile production line in Germany. AMAC’s Dr. Michael Effing and MCAM’s Roth Dothagen. Photo Credit: Mitsubishi Chemical Advanced Materials On April 11,  Mitsubishi Chemical Advanced Materials AG  (MCAM, Lenzburg, Switzerland), a global chemistry and sustainable advanced materials company, and advisory and consultancy firm AMAC GmbH (Aachen, Germany), led by Dr. Michael Effing, managing director, have announced a cooperation to strengthen and develop both company’s composite business activities in Europe. The main focus of this partnership will be on the transportation, electrics and electronics sectors, as well as sports and consumer goods. Said to be a pioneer of business development in thermoplastics, Dr. Effing has more than two decades of industry experience building up successful businesses. In the past 25 years, MCAM’s head of sales for composites, Rolf Dothagen, has also developed various thermoset businesses successfully and scaled them up. Now, with this investment and cooperation, he will now focus with MCAM on the sustainable thermoplastic composites. Both companies are also looking forward to working together on the European rollout of MCAM’s KyronTEX business. This includes MCAM’s new high-volume €10 million KyronTEX production line that was inaugurated in Heinsberg, Germany, on May 10. The site will offer a capacity of up to 5,000 tons/year, and will initially support the production of KyronTEX for the global market. KyronTEX textiles can be applied in the high-volume production of battery cases, electric vehicle (EV) charging stations body parts, delivery trucks and buses, helmets, e-bikes, train interiors and containers, to name just a few examples. Meet MCAM and AMAC at JEC World 2022 in hall 6, booth H50.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.